NovaMin Announces $4.4 Million Financing; Oral Biomaterials Company Closes First Institutional Round

ALACHUA, Fla.--(BUSINESS WIRE)--April 25, 2005--NovaMin Technology, Inc. ("NTI"), a company focused on proprietary oral health active ingredients, announced today that it has closed a $4.4 million financing round. Durham, North Carolina-based Intersouth Partners led the Series B round. The financing, which will be used to continue product development, is the company's first institutional financing. Garheng Kong and Chris Hegele, both of Intersouth Partners, will join the company's Board of Directors.